Money Concepts Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Money Concepts Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$424K	Buy	3,322 +366	+12%	+$45.7K	0.02%	402
2025 Q4	$360K	Buy	2,956 +797	+37%	+$91.4K	0.02%	398
2025 Q3	$216K	Buy	+2,159	New	+$194K	0.01%	444
2025 Q1	–	Sell	-245,148	Closed	-$22.1M	–	445
2024 Q4	$22.1M	Buy	245,148 +13,875	+6%	+$1.34M	1.64%	12
2024 Q3	$22.8M	Buy	231,273 +62,098	+37%	+$6.1M	1.73%	11
2024 Q2	$15.7M	Buy	169,175 +26,198	+18%	+$2.35M	1.32%	16
2024 Q1	$13.6M	Buy	+142,977	New	+$13.3M	1.25%	15
2023 Q2	–	Sell	-70,832	Closed	-$1.39M	–	499
2023 Q1	$1.39M	Buy	70,832 +64,640	+1,044%	+$5.36M	0.08%	177
2022 Q4	$514K	Buy	6,192 +4,435	+252%	+$359K	0.02%	426
2022 Q3	$139K	Sell	1,757 -1,022	-37%	-$86.2K	0.01%	497
2022 Q2	$213K	Sell	2,779 -7,908	-74%	-$594K	0.02%	400
2022 Q1	$961K	Buy	10,687 +7,856	+277%	+$725K	0.05%	306
2021 Q4	$317K	Buy	+2,831	New	+$341K	0.03%	398
2021 Q1	$518K	Sell	3,815 -4,544	-54%	-$680K	0.04%	308
2020 Q4	$1.18M	Buy	+8,359	New	+$1.07M	0.11%	166

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Money Concepts Capital's XBI Position: Q1 2026 in Review

Money Concepts Capital increased its State Street SPDR S&P Biotech ETF (XBI) stake by 12% in Q1 2026, buying an estimated $45.7K and bringing the position to 3,322 shares worth $424K. The position accounts for 0.02% of the portfolio, ranked #402.

Money Concepts Capital first reported a position in XBI in Q4 2020 and has held it in 15 quarters since. The position peaked at $22.8M in Q3 2024. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Money Concepts Capital held 3,322 shares of State Street SPDR S&P Biotech ETF worth $424K as of Q1 2026.
Money Concepts Capital bought 366 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $45.7K.
State Street SPDR S&P Biotech ETF made up 0.02% of Money Concepts Capital's portfolio in Q1 2026, its #402 holding.
Money Concepts Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 15 quarters since.
Money Concepts Capital's State Street SPDR S&P Biotech ETF position peaked at $22.8M in Q3 2024.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Money Concepts Capital's 13F filing for Q1 2026, filed 30 Apr 2026.